Gandhar Oil Refinery (India) Ltd

The transcript provided does not specify details regarding the current or expected order book or pending orders for Gandhar Oil Refinery India Limited. No explicit information about order backlog or pending orders was discussed in the Q4 & FY24 earnings conference call or the related Q&A session documented on the provided pages. If you need detailed data on order book, it is recommended to refer to the company's official financial disclosures, investor presentations, or reach out directly via their investor relations contacts mentioned at the end of the call.

- The transcript does not mention any current or planned new fundraising through debt or equity. - There is mention of capital expenditure of around Rs. 40 crore expected in the coming year, which includes Rs. 28 crore from the IPO proceeds (capital expenditure at Silvassa plant) and additional Rs. 10-12 crore for other plants. - No explicit discussion of raising additional debt or equity financing is provided during the call. - The company appears to fund its expansions and capital expenditure through internal accruals and IPO proceeds rather than new fundraising. - Overall, no new fundraising activities through debt or equity were indicated in the Q4 & FY24 earnings conference call.

- Approx. Rs. 28 crores capital expenditure at Silvassa is ongoing and expected to be completed by end of FY25. - Additional Rs. 10-12 crores of capital expenditure planned for other plants. - Total near-term capex guidance is around Rs. 40 crores for the coming year. - The company is implementing technological upgrades like SCADA systems and jet machine technologies to improve efficiency, reduce wastages, and enhance customer experience. - Investments in high-end laboratory equipment to ensure strict quality control. - Focus on R&D for developing sustainable and natural product alternatives, including green products and ester-based transformer oil. - Incremental capacity expansion at Taloja facility (75,000 KL) will take about three years to reach full utilization. - Sharjah facility capacity utilization aimed to reach 80-85% in FY25 and 100% by FY26.

- The company anticipates a volume growth of 12% to 15% annually, continuing its historical average growth of around 15% over the past three years. - Revenue growth is expected to be driven by volume increase, new product launches, and expanded capacity utilization. - Increasing share of PHPO (personal care and healthcare oil) segment, which has higher margins, will contribute to improved overall profitability. - Enhancements in capacity utilization, especially at the Sharjah unit (expected to reach 85-90% by next year) and Taloja facility (targeting 80% by FY26), will support volume growth. - Exports are increasing year-on-year, contributing to the overall sales growth. - The company is focused on innovation, product diversification, expanding customer base domestically and internationally, and enhancing technological capabilities to sustain growth. - Good rural demand recovery and strong monsoon expectations support optimistic volume growth forecasts.

- Gandhar Oil targets a minimum 15% volume growth annually as the base scales higher (Indrajit Bhattacharyya). - Historically, the company grew 20-25% volume per annum but is adopting a more sustainable 15% guidance now. - The PHPO segment, with higher margins (~Rs. 1000-1500 more per KL), is a growth focus, expected to improve overall gross and EBITDA margins. - For FY25, volume growth guidance is 12%-15%, driven by rural FMCG recovery and export business growth. - Margins at subsidiary Texol are expected to align with standalone margins by end of FY25, supporting consolidated profitability. - Capacity utilization, especially at Sharjah and Taloja plants, is projected to improve (Sharjah up to 85-90% by next year, Taloja ~80% by FY26), supporting volume and earnings growth. - Investments in R&D and green, natural specialty oils aim to capture premium segments, supporting medium-to-long-term earnings growth.